Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Apolipoprotein A-Ib as a biomarker of focal segmental glomerulosclerosis recurrence after kidney transplantation: diagnostic performance and assessment of its prognostic value – a multi-centre cohort study

  • Puig-Gay, N.
  • Jacobs-Cacha, C.
  • Sellarès, J.
  • Guirado, L.
  • González Roncero, F.
  • Jiménez, C.
  • Zárraga, S.
  • Paul, J.
  • Lauzurica, R.
  • Alonso, Á.
  • Fernández, A.
  • Beneyto, I.
  • Mazuecos, A.
  • Hernández, D.
  • Rodriguez-Benot, A.
  • Franco, A.
  • Jimeno, L.
  • Crespo, M.
  • Meseguer, A.
  • Moreso, F.
  • Seron, D.
  • Lopez-Hellin, J.
  • Cantarell, C.
Recurrence of idiopathic focal segmental glomerulosclerosis (FSGS) is a serious complication after kidney transplantation. FSGS relapse is suspected by a sudden increase in proteinuria but there is not an accurate noninvasive diagnostic tool to confirm this entity or to detect patients at risk. We aimed to validate the diagnostic performance of ApoA-Ib to detect FSGS relapses by measuring urinary ApoA-Ib in a retrospective cohort of 61 kidney transplanted patients (37 FSGS and 24 non-FSGS). In addition, to assess the ApoA-Ib predictive ability, ApoA-Ib was measured periodically in a prospective cohort of 13 idiopathic FSGS patients who were followed during 1 year after transplantation. ApoA-Ib had a sensitivity of 93.3% and a specificity of 90.9% to diagnose FSGS relapses, with a high negative predictive value (95.2%), confirming our previous results. In the prospective cohort, ApoA-Ib predated the recurrence in four of five episodes observed. In the nonrelapsing group (n = 9), ApoA-Ib was negative in 37 of 38 samples. ApoA-Ib has the potential to be a good diagnostic biomarker of FSGS relapses, providing a confident criterion to exclude false positives even in the presence of high proteinuria. It has also the potential to detect patients at risk of relapse, even before transplantation.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A Specific Tubular ApoA-I Distribution Is Associated to FSGS Recurrence after Kidney Transplantation

  • Jacobs-Cacha, Conxita
  • Puig-Gay, Natalia
  • Gabaldón Domínguez, María Alejandra
  • Sellarès , Joana
  • Villena-Ortiz, Yolanda
  • Agraz Pamplona, Irene
  • Soler Romeo, Maria Jose
  • Seron, Daniel
  • Vergara, Ander
  • Moreso, Francesc
  • Lopez Hellin, Joan
Malaltia glomerular; Trasplantament de ronyó; Recurrència, Enfermedad glomerular; Trasplante de riñón; Recurrencia, Glomerular disease; Kidney transplantation; Recurrence, A major complication of primary focal segmental glomerulosclerosis (FSGS) is its recurrence after kidney transplantation that happens in 30 to 40% of the patients. The diagnosis of these relapses is not always easy as the histological lesions are not highly specific and appear after the proteinuria increase. Currently, there are no accurate biomarkers to detect FSGS recurrence. Our group identified a modified form of Apolipoprotein A-I (ApoA-I), named ApoA-Ib, specifically present in the urine of recurrent FSGS patients after kidney transplantation. Aberrant forms of ApoA-I have also been described in the urine of native primary FSGS patients; this feature has been associated with prominent staining of ApoA-I at the apical membrane of the tubular cells. In this study, we aim to analyze the ApoA-I distribution in kidney allograft biopsies of recurrent FSGS patients. We detected ApoA-I by immunohistochemistry in kidney allograft biopsies of patients with FSGS relapse after kidney transplantation and in kidney allograft biopsies of patients with a disease different from FSGS in the native kidney (non-FSGS). In recurrent FSGS patients, ApoA-I was prominently localized at the brush border of the tubular cells, while in the non-FSGS patients, ApoA-I was found along the cytoplasm of the tubular cells. The localization of ApoA-I at the brush border of the tubular cells is a specific feature of primary FSGS in relapse. This suggests that ApoA-I staining in kidney biopsies, coupled with ApoA-Ib measurement in urine, could be used as a diagnostic tool of primary FSGS relapse after kidney transplantation due to its highly specific tubular distribution., This research was funded by Fondo de Investigación Sanitaria-Feder, Instituto de Salud Carlos III, grant number PI14/00275 and by Fundació la Marató de TV3, grant number 759/U/2020.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

A Specific Tubular ApoA-I Distribution Is Associated to FSGS Recurrence after Kidney Transplantation

  • Jacobs-Cacha, Conxita
  • Puig-Gay, Natalia
  • Gabaldón Domínguez, María Alejandra
  • Sellarès , Joana
  • Villena Ortiz, Yolanda
  • Agraz Pamplona, Irene
  • Soler Romeo, Maria Jose
  • Seron, Daniel
  • Vergara, Ander
  • Moreso, Francesc
  • Lopez Hellin, Joan
Malaltia glomerular; Trasplantament de ronyó; Recurrència, Enfermedad glomerular; Trasplante de riñón; Recurrencia, Glomerular disease; Kidney transplantation; Recurrence, A major complication of primary focal segmental glomerulosclerosis (FSGS) is its recurrence after kidney transplantation that happens in 30 to 40% of the patients. The diagnosis of these relapses is not always easy as the histological lesions are not highly specific and appear after the proteinuria increase. Currently, there are no accurate biomarkers to detect FSGS recurrence. Our group identified a modified form of Apolipoprotein A-I (ApoA-I), named ApoA-Ib, specifically present in the urine of recurrent FSGS patients after kidney transplantation. Aberrant forms of ApoA-I have also been described in the urine of native primary FSGS patients; this feature has been associated with prominent staining of ApoA-I at the apical membrane of the tubular cells. In this study, we aim to analyze the ApoA-I distribution in kidney allograft biopsies of recurrent FSGS patients. We detected ApoA-I by immunohistochemistry in kidney allograft biopsies of patients with FSGS relapse after kidney transplantation and in kidney allograft biopsies of patients with a disease different from FSGS in the native kidney (non-FSGS). In recurrent FSGS patients, ApoA-I was prominently localized at the brush border of the tubular cells, while in the non-FSGS patients, ApoA-I was found along the cytoplasm of the tubular cells. The localization of ApoA-I at the brush border of the tubular cells is a specific feature of primary FSGS in relapse. This suggests that ApoA-I staining in kidney biopsies, coupled with ApoA-Ib measurement in urine, could be used as a diagnostic tool of primary FSGS relapse after kidney transplantation due to its highly specific tubular distribution., This research was funded by Fondo de Investigación Sanitaria-Feder, Instituto de Salud Carlos III, grant number PI14/00275 and by Fundació la Marató de TV3, grant number 759/U/2020.